Get started
Author

Xinghe Tong

M2 macrophages-derived exosomal miR-3917 promotes the progression of lung cancer via targeting GRK6
2022 · Sinuo Song, Yunping Zhao, et al. · Biological Chemistry · 12
The role of histone methyltransferases in therapeutic resistance of NSCLC
2025 · Fuze Zhu, Xudong Yang, et al. · Epigenetics · 5
PDF
Characteristics of the microbiome in lung adenocarcinoma tissue from patients in Kunming city of southwestern China
2023 · Manjun Chen, Yue Cui, et al. · Environmental Science and Pollution Research · 5
Nanomaterial assisted natural killer cell therapy
2025 · Xuan Yu, Xiaobo Chen, et al. · Frontiers in Immunology · 4
PDF
Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non‐small cell lung cancer
2024 · Jie Tang, Yingsong Tian, et al. · Clinical and Translational Medicine · 3
The dual role of PCDH9 in tumors, neurological and developmental diseases
2025 · Haohan Li, Yuan Wang, et al. · Medical Oncology · 2
Effects of primary tumor location in the basal segment or superior segment (S6) on patient survival in lung cancer: a meta-analysis
2025 · Xuan Yu, Yanlong Yang, et al. · World Journal of Surgical Oncology · 1
PDF
A fibroblast activation protein degrader enhances cisplatin sensitivity in non‑small cell lung cancer
2026 · Yong Zhou, Ranhua Li, et al. · Oncology Reports
[Advances in the Treatment of Multiple Primary Lung Cancer].
2025 · Ying Xiao, Xiaobo Chen, et al. · PubMed
Abstract 3263: Assessing molecular residual disease via early postoperative plasma circulating tumor DNA for recurrence risk evaluation in non-small cell lung cancer following radical resection
2025 · Jie Tang, Yingsong Tian, et al. · Cancer Research
Works count: 10
Citation count: 32
H-index: 4
I10-index: 1
Year
Topic
Type